How can we maintain long-term venous access in patients with intestinal failure? How can we prevent infections, arguably the most dangerous complications in central-venous catheters?

The answer to these questions may lie in taurolidine, an antimicrobial agent with broad antibacterial and antifungal efficacy.  
At the “Insights Intestinal Failure”conference, two experts will share their perspective on the matter.  

Everybody is welcome to attend our industry symposium “Taurolidine: The Silver Bullet Against Catheter-Related Infections”. Jakub Víšek, MD, Ph.D. and Dr. Samford Wong will talk about the use of taurolidine-based lock solutions both as a well-established standard and in new fields where infections still hinder treatment success. The common goal is to accelerate progress and thereby reduce morbidity, mortality, and healthcare costs.

18 May, 02:45-03:45 pm CET at the Novotel Paris Centre Tour Eiffel.

Jakub Víšek, MD, Ph.D.

3rd Department of Gerontology and Metabolism, University Hospital Hradec Králové, Czechia 

Recent publication: 
Visek et al. In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition. Nutrition 2023. DOI: 10.1016/j.nut.2023.112115  

Dr. Samford Wong

Lead Dietitian – National Spinal Injuries Centre at Stoke Mandeville Hospital, UK 
Honorary Reader / Associate Professor – City St George’s, University of London, UK 

Recent publication: 
Wong et al. Use of Taurolidine in preventing catheter-related blood stream infections in spinal cord injury patients – a quality improvement initiative to reduce adverse effects associated with parenteral nutrition. Abstract presented at ESPEN Congress 2025.